{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:46:07Z","timestamp":1782737167698,"version":"3.54.5"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Importance:<\/jats:title>\n                    <jats:p>Femoral vein access used to be the traditional approach for adrenal venous sampling (AVS) procedures, whereas antecubital vein access is the newly developed approach. Until now, no randomized trial for comparison of two approaches has been carried out.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To compare the success rate, safety, and procedural parameters of AVS via an antecubital approach versus femoral approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>This randomized clinical trial (RCT) was conducted between January 2022 and December 2023. The patients with primary aldosteronism (PA) aged 18\u201360\u00a0years were randomly assigned to femoral vein access group (FV) or antecubital vein access group (AV). The intention-to-treat analysis included all randomized patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants:<\/jats:title>\n                    <jats:p>A total of 675 patients aged 18\u201360\u00a0years old with hypertension that were at increased risk for PA were screened, 183 of whom were confirmed with PA. Twenty-nine patients were excluded due to refusal of AVS, decline of participating in this trial, or contraindication to AVS. A total of 154 patients were recruited in this trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention:<\/jats:title>\n                    <jats:p>Patients were randomly assigned to undergo AVS via femoral approach or antecubital approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcomes and measures:<\/jats:title>\n                    <jats:p>The primary end point was the success rate of bilateral AVS. Secondary end points included the success rate of right, left sampling, procedure duration, fluoroscopy time, contrast volume, incidence of complications, and postsurgical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      From January 2022 to December 2023, totally 154 patients with PA were randomized to FV group (77cases, mean age, 47.8\u00a0\u00b1\u00a08.1\u00a0years; 26 females [33.8%]) and AV group (77cases, mean age, 49.2\u00a0\u00b1\u00a08.6\u00a0years; 30 females [39%]). The baseline characteristics for the two groups were well balanced (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt;\u00a00.05). There were no significant differences in the success rate of bilateral (89.6% vs 92.2%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.58),right (94.8% vs 97.4%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.68), and left (94.8% vs 94.8%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a01.00) sampling between two groups. The incidence of complications did not differ between the two groups (2.6% vs 0,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.477). The incidence of arterial mis-puncture was significantly higher in FV group than that in AV group (0% vs 9.1%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.02). The fluoroscopy time and contrast volume did not significantly differ between two groups. The procedure duration in AV group was significantly shorter than that of FV group (18.0 [IQR, 15.0\u201323.0] versus 20.0 [IQR, 17.0\u201325.5],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.011). There was no significant difference in the proportion of patients who achieved complete clinical success (50.0% vs 45.9%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.725) and complete biochemical success (92.1% vs 91.9%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a01.000) after adrenalectomy between FV group and AV group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and relevance:<\/jats:title>\n                    <jats:p>The trial showed AVS via AV approach or FV approach did not lead to significant differences in success rate and incidence of complications, as well as postsurgical outcomes. However, AV approach was associated with shorter procedure duration, no arterial mis-puncture and earlier ambulation after the procedure, which make it a better alternative to FV approach.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000002452","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T11:01:45Z","timestamp":1747134105000},"page":"4508-4515","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Antecubital versus femoral approach for adrenal venous sampling in the patients with primary aldosteronism: a randomized controlled trial"],"prefix":"10.1097","volume":"111","author":[{"given":"Hui","family":"Dong","sequence":"first","affiliation":[{"name":"Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College\/National Center for Cardiovascular Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1230-4081","authenticated-orcid":false,"given":"Hongwu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0187-8379","authenticated-orcid":false,"given":"Xiongjing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"R1-20260629","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.jacc.2019.09.057","article-title":"Primary aldosteronism: JACC state-of-the-art review","volume":"74","author":"Rossi","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R2-20260629","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R3-20260629","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertension"},{"key":"R4-20260629","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/HYPERTENSIONAHA.121.18342","article-title":"Higher plasma aldosterone concentrations are associated with elevated risk of aortic dissection and aneurysm: a case-control study","volume":"79","author":"Zhu","year":"2022","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"R5-20260629","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: the German Conn\u2019s registry","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension"},{"key":"R6-20260629","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"key":"R7-20260629","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"key":"R8-20260629","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R9-20260629","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2214\/AJR.07.3338","article-title":"Radiologic anatomy of the right adrenal vein: preliminary experience with MDCT","volume":"191","author":"Matsuura","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"R10-20260629","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/HYPERTENSIONAHA.116.08375","article-title":"Anatomical variations of the right adrenal vein: concordance between multidetector computed tomography and catheter venography","volume":"69","author":"Omura","year":"2017","journal-title":"Hypertension"},{"key":"R11-20260629","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-20260629","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00270-016-1524-x","article-title":"A novel method of adrenal venous sampling via an antecubital approach","volume":"40","author":"Jiang","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R13-20260629","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1210\/clinem\/dgad433","article-title":"Adrenal venous sampling via an antecubital approach in primary aldosteronism: a multicenter study","volume":"109","author":"Dong","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-20260629","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/HYPERTENSIONAHA.119.13463","article-title":"Clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling","volume":"74","author":"Rossi","year":"2019","journal-title":"Hypertension"},{"key":"R15-20260629","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"R16-20260629","first-page":"606","article-title":"Evaluation of chemiluminescence immunoassay for detecting blood levels of aldosterone and renin with its diagnostic value of primary aldosteronism","volume":"31","author":"Wang","year":"2016","journal-title":"Chin Circ J"},{"key":"R17-20260629","doi-asserted-by":"crossref","first-page":"1183161","DOI":"10.3389\/fendo.2023.1183161","article-title":"Captopril challenge test in the diagnosis of primary aldosteronism: consistency between 1- and 2-\u00a0h sampling","volume":"14","author":"Liu","year":"2023","journal-title":"Front Endocrinol"},{"key":"R18-20260629","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"key":"R19-20260629","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1097\/HJH.0000000000002520","article-title":"Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J. Hypertension"},{"key":"R20-20260629","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R21-20260629","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/HYPERTENSIONAHA.110.168484","article-title":"Adrenal venous sampling: evaluation of the German Conn\u2019s registry","volume":"57","author":"Vonend","year":"2011","journal-title":"Hypertension"},{"key":"R22-20260629","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","article-title":"Primary aldosteronism: practical approach to diagnosis and management","volume":"138","author":"Byrd","year":"2018","journal-title":"Circulation"},{"key":"R23-20260629","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s42155-021-00220-y","article-title":"Adrenal vein sampling: technique and protocol, a systematic review","volume":"4","author":"Quencer","year":"2021","journal-title":"CVIR Endovascular"},{"key":"R24-20260629","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1210\/clinem\/dgz017","article-title":"Subtyping of primary aldosteronism in the AVIS-2 study: assessment of selectivity and lateralization","volume":"105","author":"Rossitto","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-20260629","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R26-20260629","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2011-2830","article-title":"The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism","volume":"97","author":"Rossi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-20260629","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/joim.12831","article-title":"Diagnosis and treatment of primary aldosteronism: practical clinical perspectives","volume":"285","author":"Young","year":"2019","journal-title":"J Internal Med"},{"key":"R28-20260629","doi-asserted-by":"crossref","first-page":"e2338209","DOI":"10.1001\/jamanetworkopen.2023.38209","article-title":"Corticotropin stimulation in adrenal venous sampling for patients with primary aldosteronism: the ADOPA randomized clinical trial","volume":"6","author":"Yang","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R29-20260629","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12020-022-03122-8","article-title":"Adrenal venous sampling in primary aldosteronism: experience of a Spanish multicentric study (Results from the SPAIN-ALDO Register)","volume":"78","author":"Araujo-Castro","year":"2022","journal-title":"Endocrine"},{"key":"R30-20260629","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/HYPERTENSIONAHA.115.06305","article-title":"Clinical management and outcomes of adrenal hemorrhage following adrenal vein sampling in primary aldosteronism","volume":"67","author":"Monticone","year":"2016","journal-title":"Hypertension"},{"key":"R31-20260629","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/europace\/eux175","article-title":"Ultrasound-guided versus conventional femoral venipuncture for catheter ablation of atrial fibrillation: a multicentre randomized efficacy and safety trial (ULTRA-FAST trial)","volume":"20","author":"Yamagata","year":"2018","journal-title":"Europace"},{"key":"R33-20260629","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1161\/CIRCULATIONAHA.109.921460","article-title":"Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study","volume":"121","author":"Holst","year":"2010","journal-title":"Circulation"},{"key":"R34-20260629","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S0049-3848(17)30068-3","article-title":"The effect of BMI on haemostasis: implications for thrombosis in women\u2019s health","volume":"151","author":"Hunt","year":"2017","journal-title":"Thromb Res"},{"key":"R35-20260629","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/jch.12916","article-title":"Proportion of patients with hypertension resolution following adrenalectomy for primary aldosteronism: a systematic review and meta-analysis","volume":"18","author":"Benham","year":"2016","journal-title":"J Clin Hypertension"},{"key":"R36-20260629","first-page":"277","article-title":"Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronism","volume":"110","author":"Hannon","year":"2017","journal-title":"Qjm"},{"key":"R37-20260629","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.surg.2020.07.046","article-title":"Long-term outcome success after operative treatment for primary aldosteronism","volume":"169","author":"Picado","year":"2021","journal-title":"Surgery"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002452","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:03:50Z","timestamp":1782734630000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000002452","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"2024-10-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}